• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期非精原细胞瘤性睾丸癌的预后因素。多因素逻辑回归分析。

Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis.

作者信息

Droz J P, Kramar A, Ghosn M, Piot G, Rey A, Theodore C, Wibault P, Court B H, Perrin J L, Travagli J P

机构信息

Department of Medicine, Institut Gustave-Roussy, Ville-juif-France.

出版信息

Cancer. 1988 Aug 1;62(3):564-8. doi: 10.1002/1097-0142(19880801)62:3<564::aid-cncr2820620321>3.0.co;2-a.

DOI:10.1002/1097-0142(19880801)62:3<564::aid-cncr2820620321>3.0.co;2-a
PMID:2455591
Abstract

In order to define prognostic factors for advanced stage of nonseminomatous germ cell tumors (NSGCT) of the testis, the authors reviewed 84 patients treated from 1978 through 1985. The survival rate was 51% at 3 years. Patients with elevated seric levels of human chorionic gonadotropin (HCG) and/or alpha-fetoprotein (AFP), or the presence of an abdominal mass had significantly worse survival. Only HCG and AFP levels retained their significance when multivariate Cox analysis was performed. The probability that a patient achieves a complete remission (CR) was assessed by a function of certain patient characteristics using a multivariate logistic regression analysis. The significant variables were a function of HCG and AFP values. Since both variables are related to the CR rate and survival the authors define the obtention of a CR as a unique outcome of interest. The probability of a CR greater than 70% adequately separates the patients into two prognostic subgroups. This model currently is being used to enrole NSGCT patients in a prospective modulated clinical trial according to these prognostic factors.

摘要

为了确定睾丸非精原细胞瘤(NSGCT)晚期的预后因素,作者回顾了1978年至1985年期间接受治疗的84例患者。3年生存率为51%。血清人绒毛膜促性腺激素(HCG)和/或甲胎蛋白(AFP)水平升高或存在腹部肿块的患者生存率明显较差。进行多变量Cox分析时,只有HCG和AFP水平仍具有统计学意义。通过多变量逻辑回归分析,根据某些患者特征的函数评估患者实现完全缓解(CR)的概率。显著变量是HCG和AFP值的函数。由于这两个变量均与CR率和生存率相关,作者将获得CR定义为唯一感兴趣的结果。CR概率大于70%可将患者充分分为两个预后亚组。目前,该模型正用于根据这些预后因素将NSGCT患者纳入一项前瞻性调整临床试验。

相似文献

1
Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis.晚期非精原细胞瘤性睾丸癌的预后因素。多因素逻辑回归分析。
Cancer. 1988 Aug 1;62(3):564-8. doi: 10.1002/1097-0142(19880801)62:3<564::aid-cncr2820620321>3.0.co;2-a.
2
Prognostic factors in metastatic nonseminomatous germ cell tumours.转移性非精原细胞瘤性生殖细胞肿瘤的预后因素
Can J Surg. 1993 Dec;36(6):537-40.
3
Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.化疗开始时的肿瘤标志物浓度比标志物半衰期更能有力地预测治疗失败:一项针对播散性非精原细胞瘤性睾丸癌患者的研究。
Br J Cancer. 1997;75(3):432-5. doi: 10.1038/bjc.1997.71.
4
Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery.晚期生殖细胞肿瘤血清肿瘤标志物与化疗及手术反应的相关性
Cancer. 1984 Mar 15;53(6):1440-5. doi: 10.1002/1097-0142(19840315)53:6<1440::aid-cncr2820530637>3.0.co;2-g.
5
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.未经选择的非精原细胞转移性睾丸癌患者的预后因素:一项多中心研究经验
J Clin Oncol. 1991 May;9(5):818-26. doi: 10.1200/JCO.1991.9.5.818.
6
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.模型化 AUC(AFP-hCG)的预测价值,这是一个描述血清肿瘤标志物在非精原细胞瘤生殖细胞肿瘤患者中下降的动态动力学参数。
Urology. 2010 Aug;76(2):423-9.e2. doi: 10.1016/j.urology.2010.02.049. Epub 2010 May 15.
7
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.非精原细胞瘤性睾丸癌化疗开始后血清甲胎蛋白激增具有不良预后意义。
Br J Cancer. 1998 Nov;78(10):1350-5. doi: 10.1038/bjc.1998.683.
8
Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.早期血清肿瘤标志物半衰期在转移性睾丸畸胎瘤中的预后意义
J Clin Oncol. 1995 Jan;13(1):87-92. doi: 10.1200/JCO.1995.13.1.87.
9
The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).不同预后非精原细胞瘤生殖细胞肿瘤患者肿瘤标志物水平的预后影响:国际全球生殖细胞肿瘤协作组(G3)登记处。
Urol Oncol. 2019 Nov;37(11):809.e19-809.e25. doi: 10.1016/j.urolonc.2019.07.020. Epub 2019 Sep 5.
10
Lens Culinaris Agglutinin-reactive Fraction of Alpha-fetoprotein as a Tumor Marker in a Patient With Nonseminomatous Germ Cell Tumor With Normal Alpha-fetoprotein Level.甲胎蛋白的菜豆凝集素反应性部分作为甲胎蛋白水平正常的非精原性生殖细胞肿瘤患者的肿瘤标志物
Clin Genitourin Cancer. 2020 Jun;18(3):e309-e311. doi: 10.1016/j.clgc.2019.12.013. Epub 2019 Dec 20.

引用本文的文献

1
Impact of Non-Pulmonary Visceral Metastases in the Prognosis and Practice of Metastatic Testicular Germ Cell Tumors.非肺内脏转移对转移性睾丸生殖细胞肿瘤预后及治疗的影响
Oncol Rev. 2016 Apr 20;10(1):292. doi: 10.4081/oncol.2016.292. eCollection 2016 Apr 15.
2
Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer.风险适应性管理中转移性睾丸生殖细胞癌化疗的现状。
Cancer Sci. 2010 Jan;101(1):22-8. doi: 10.1111/j.1349-7006.2009.01373.x. Epub 2009 Sep 26.
3
Good-risk-advanced germ cell tumors: historical perspective and current standards of care.
低风险晚期生殖细胞肿瘤:历史回顾与当前治疗标准
World J Urol. 2009 Aug;27(4):463-70. doi: 10.1007/s00345-009-0431-z. Epub 2009 Jun 10.
4
Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors.非精原细胞性生殖细胞肿瘤肺转移化疗后急性呼吸窘迫综合征
Support Care Cancer. 2003 Sep;11(9):575-80. doi: 10.1007/s00520-003-0481-5. Epub 2003 Jun 3.
5
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.非精原细胞瘤性睾丸癌化疗开始后血清甲胎蛋白激增具有不良预后意义。
Br J Cancer. 1998 Nov;78(10):1350-5. doi: 10.1038/bjc.1998.683.
6
Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.化疗开始时的肿瘤标志物浓度比标志物半衰期更能有力地预测治疗失败:一项针对播散性非精原细胞瘤性睾丸癌患者的研究。
Br J Cancer. 1997;75(3):432-5. doi: 10.1038/bjc.1997.71.
7
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.转移性睾丸生殖细胞肿瘤患者非Ras 21 kDa蛋白的分析
J Cancer Res Clin Oncol. 1993;119(11):685-8. doi: 10.1007/BF01215988.
8
Super-high-risk germ-cell tumors: a clinical entity. Report of eleven cases.超高风险生殖细胞肿瘤:一种临床实体。11例报告。
Support Care Cancer. 1994 Jul;2(4):253-8. doi: 10.1007/BF00365732.
9
Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?低危生殖细胞肿瘤中的急性肿瘤溶解综合征:它存在吗?
Support Care Cancer. 1994 Mar;2(2):128-31. doi: 10.1007/BF00572095.